International Clinical Trial: TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825688) titled 'TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).

Primary Sponsor: Duke University

Condition: Delayed Graft Function

Intervention: Device: TxAccess

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 15, 2026

Target Sample Size: 450

To know more, visit https://clinicaltrials.gov/study/NCT07825688

Published by HT Digital Content Services with permission from ...